Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011269
Filing Date
2018-05-07
Accepted
2018-05-07 16:38:35
Documents
53
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q scph-10q_20180331.htm 10-Q 797849
2 EX-31.1 scph-ex311_9.htm EX-31.1 10764
3 EX-31.2 scph-ex312_8.htm EX-31.2 10548
4 EX-32.1 scph-ex321_7.htm EX-32.1 8087
5 EX-32.2 scph-ex322_6.htm EX-32.2 7986
  Complete submission text file 0001564590-18-011269.txt   3555875

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT scph-20180331.xml EX-101.INS 725384
7 XBRL TAXONOMY EXTENSION SCHEMA scph-20180331.xsd EX-101.SCH 34318
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scph-20180331_cal.xml EX-101.CAL 39893
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scph-20180331_def.xml EX-101.DEF 76582
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20180331_lab.xml EX-101.LAB 255318
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20180331_pre.xml EX-101.PRE 192425
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38293 | Film No.: 18811769
SIC: 2834 Pharmaceutical Preparations